Antitumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis and limited effective treatment. The rise in immunotherapeutic strategies prompted the establishment of a genetic vaccine against TNBC in vitro using a possible biological marker of TNBC. In the present study, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Mi, Liu, Yu, Zhang, Qiao-Chu, Zhang, Peng, Wu, Jue-Kun, Wang, Jia-Ni, Ruan, Ying, Huang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096217/
https://www.ncbi.nlm.nih.gov/pubmed/30127867
http://dx.doi.org/10.3892/ol.2018.9001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096217/
https://www.ncbi.nlm.nih.gov/pubmed/30127867
http://dx.doi.org/10.3892/ol.2018.9001

Ejemplares similares